Internal Medicine · Peoria, AZ
NPI
1356321392
Since 2006
Specialty
Internal Medicine
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
6760 W Thunderbird Rd Ste E100
Peoria, AZ, 85381
Phone (623) 241-9028
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,125 services
Medicare patients, 2024
201
Average age 72
Drug cost, 2024
$6.7M
8,610 prescriptions
Company payments, 2025
$1,539
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chioma N Iweha was code 99214 (office e&m - established), 567 times for 193 patients. In total Chioma N Iweha billed 1,125 services in 19 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 567 | 193 | $90.07 | $51K |
| 82962 Clinical Chemistry | Office | 338 | 107 | $3.20 | $1,082 |
| 95251 Test - Miscellaneous | Office | 104 | 44 | $25.71 | $2,674 |
| 99204 Office E&M - New | Office | 33 | 33 | $110.49 | $3,646 |
By year: 2022 $66K for 1,140 services; 2023 $66K for 1,179 services; 2024 $62K for 1,125 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 338 | 107 | $3.20 | $1,082 |
Medicare prescription drug claims, 2024
In 2024, the drug Chioma N Iweha prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,199 prescriptions and refills. In total Chioma N Iweha wrote 8,610 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,199 | 2,357 | 251 | $8,210 |
| Pioglitazone Hcl Generic | 590 | 1,303 | 141 | $6,140 |
| Metformin Hcl Generic | 522 | 1,223 | 148 | $4,135 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 388 | 880 | 147 | $43K |
| Tresiba Flextouch U-200 Insulin Degludec | 350 | 662 | 91 | $292K |
| Mounjaro Tirzepatide | 343 | 385 | 69 | $414K |
| Ozempic Semaglutide | 297 | 395 | 59 | $366K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 223 | 500 | 61 | $264K |
| Jardiance Empagliflozin | 219 | 368 | 52 | $213K |
| Glimepiride Generic | 136 | 265 | 28 | $862 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 129 | 226 | 35 | $18K |
| Atorvastatin Calcium Generic | 126 | 272 | 35 | $1,162 |
| Rybelsus Semaglutide | 124 | 180 | 24 | $169K |
| Fenofibrate Fenofibrate Nanocrystallized | 124 | 182 | 20 | $3,642 |
| Bromocriptine Mesylate Generic | 121 | 166 | 18 | $31K |
Brand drugs: 4,159 claims; generic drugs: 3,746 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chioma N Iweha $1,539 ($1,539 in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $285.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 16 | $285 |
| Recordati_rare_diseases_inc. | 11 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $148 |
| Corcept Therapeutics CORT | 8 | $147 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $121 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $90.63 |
| Aimmune Therapeutics, Inc. | 3 | $81.71 |
| Abbott Laboratories ABT | 3 | $53.05 |
| CeQur Corporation | 1 | $52.97 |
| Lilly USA, LLC LLY | 3 | $51.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.